Report Published: "South Korea Genetic Testing Market Outlook to 2021"

GlobalData's new report, "South Korea Genetic Testing Market Outlook to 2021", provides key market data on the South Korea Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Full Report Details at
- http://www.fastmr.com/prod/1108021_south_korea_genetic_testing.aspx?afid=301

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

* Genetic Testing market includes Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.
* Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
* 2014 company shares and distribution shares data for Genetic Testing market.
* Global corporate-level profiles of key companies operating within the South Korea Genetic Testing market.
* Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Danaher Corporation, Abbott Laboratories, Hologic, Inc., Cepheid, Bio-Rad Laboratories, Inc., Qiagen N.V., Transgenomic, Inc. and PerkinElmer, Inc.

Reasons to Get this Report

* Develop business strategies by identifying the key market segments poised for strong growth in the future.
* Develop market-entry and market expansion strategies.
* Design competition strategies by identifying who-stands-where in the market.
* Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
* What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned in this Report: Hologic, Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Transgenomic, Inc., Danaher Corporation, Siemens Healthcare, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Alere Inc.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- BRIC Genetic Testing Market Outlook to 2021
- North America Genetic Testing Market Outlook to 2021
- Canada In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
- United States In Vitro Diagnostics (IVD) Market Outlook to 2021 - Clinical Chemistry, Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Diagnostics and Microbiology Culture
- Australia Genetic Testing Market Outlook to 2021